$ACTG
ACACIA RESEARCH CORP Stock $actg

$actg Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000093454916000156 Filed on November 14, 2016

Income Statement

Concept	2016 Q4	2016 Q3	2015 Q4
Revenue	$21.97M	$64.66M	$37.50M
YoY Change	-41.41%	397.6%	20.84%
Cost Of Revenue	$3.310M	$17.84M	$7.760M
YoY Change	-57.35%	14766.67%	77.98%
Gross Profit	$18.66M	$46.81M	$29.74M
YoY Change	-37.26%	263.43%	11.51%
Gross Profit Margin	84.94%	72.4%	79.31%
Selling, General & Admin	$13.29M	$16.04M	$12.47M
YoY Change	6.58%	40.58%	-35.52%
% of Gross Profit	71.22%	34.27%	41.93%
Research & Development	$560.0K	$670.0K	$860.0K
YoY Change	-34.88%	-16.25%	34.38%
% of Gross Profit	3.0%	1.43%	2.89%
Depreciation & Amortization	$6.300M	$6.500M	$13.20M
YoY Change	-52.27%	-52.55%	29.41%
% of Gross Profit	33.76%	13.89%	44.38%
Operating Expenses	$20.07M	$23.18M	$26.69M
YoY Change	-24.8%	-21.05%	-20.8%
Operating Profit	-$9.055M	$16.29M	-$113.2M
YoY Change	-92.0%	-160.7%	642.62%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$592.0K	$261.0K	$0.00
YoY Change		-245.0%	-100.0%
Pretax Income	-$8.463M	$16.55M	-$113.2M
YoY Change	-92.52%	-161.26%	621.28%
Income Tax	$2.414M	$9.655M	$4.174M
% Of Pretax Income		58.33%
Net Earnings	-$10.61M	$7.082M	-$115.9M
YoY Change	-90.85%	-125.93%	613.56%
Net Earnings / Revenue	-48.3%	10.95%	-309.12%
Basic Earnings Per Share		$0.14
Diluted Earnings Per Share	-$211.2K	$0.14	-$2.330M
COMMON SHARES
Basic Shares Outstanding	50.46M shares	50.12M shares	50.74M shares
Diluted Shares Outstanding	50.24M shares	50.62M shares	49.75M shares

Balance Sheet

Concept	2016 Q4	2016 Q3	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$147.0M	$146.3M	$135.2M
YoY Change	8.73%	-7.29%	-29.95%
Cash & Equivalents	$139.1M	$116.0M	$135.2M
Short-Term Investments	$19.40M	$30.30M	$0.00
Other Short-Term Assets	$14.70M	$18.10M	$15.10M
YoY Change	-2.65%	7.74%	169.64%
Inventory
Prepaid Expenses
Receivables	$26.75M	$53.70M	$33.50M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$188.5M	$218.1M	$183.9M
YoY Change	2.51%	16.4%	-15.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$127.0K	$155.0K	$272.0K
YoY Change	-53.31%	-51.41%	-45.6%
Goodwill			$30.10M
YoY Change			0.0%
Intangibles
YoY Change
Long-Term Investments	$0.00	$1.700M
YoY Change
Other Assets	$618.0K	$365.0K	$1.110M
YoY Change	-44.32%	3.4%	212.68%
Total Long-Term Assets	$107.5M	$105.4M	$164.0M
YoY Change	-34.45%	-62.39%	-48.36%
TOTAL ASSETS
Total Short-Term Assets	$188.5M	$218.1M	$183.9M
Total Long-Term Assets	$107.5M	$105.4M	$164.0M
Total Assets	$296.0M	$323.5M	$347.9M
YoY Change	-14.92%	-30.82%	-35.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.30M	$22.70M	$17.30M
YoY Change	-17.34%	29.71%	14197.52%
Accrued Expenses	$0.00	$200.0K	$1.000M
YoY Change	-100.0%		-96.82%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$28.19M	$47.92M	$33.23M
YoY Change	-15.15%	79.35%	-27.63%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$369.0K	$362.0K	$311.0K
YoY Change	18.65%	24.4%	36.4%
Total Long-Term Liabilities	$369.0K	$362.0K	$311.0K
YoY Change	18.65%	24.4%	36.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$28.19M	$47.92M	$33.23M
Total Long-Term Liabilities	$369.0K	$362.0K	$311.0K
Total Liabilities	$28.56M	$48.49M	$33.75M
YoY Change	-15.37%	72.14%	-28.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$342.2M	-$331.6M	-$288.1M
YoY Change	18.76%	92.54%	124.94%
Common Stock	$50.00K	$50.00K	$51.00K
YoY Change	-1.96%	-1.96%	2.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$34.64M	$34.64M	$34.64M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	1.729M shares	1.729M shares	1.729M shares
Shareholders Equity	$265.6M	$272.9M	$310.2M
YoY Change
Total Liabilities & Shareholders Equity	$296.0M	$323.5M	$347.9M
YoY Change	-14.92%	-30.82%	-35.14%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2015 Q4
OPERATING ACTIVITIES
Net Income	-$10.61M	$7.082M	-$115.9M
YoY Change	-90.85%	-125.93%	613.56%
Depreciation, Depletion And Amortization	$6.300M	$6.500M	$13.20M
YoY Change	-52.27%	-52.55%	29.41%
Cash From Operating Activities	$10.90M	-$14.60M	-$12.10M
YoY Change	-190.08%	-269.77%	24.74%
INVESTING ACTIVITIES
Capital Expenditures	-$200.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$900.0K	-$8.100M	$0.00
YoY Change		-121.72%	-100.0%
Cash From Investing Activities	$700.0K	-$8.100M	$0.00
YoY Change		-122.25%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-1.100M	-10.40M
YoY Change	-100.0%	-82.81%	65.08%
NET CHANGE
Cash From Operating Activities	10.90M	-14.60M	-12.10M
Cash From Investing Activities	700.0K	-8.100M	0.000
Cash From Financing Activities	0.000	-1.100M	-10.40M
Net Change In Cash	11.60M	-23.80M	-22.50M
YoY Change	-151.56%	-161.66%	13.64%
FREE CASH FLOW
Cash From Operating Activities	$10.90M	-$14.60M	-$12.10M
Capital Expenditures	-$200.0K	$0.00	$0.00
Free Cash Flow	$11.10M	-$14.60M	-$12.10M
YoY Change	-191.74%	-255.32%	-240.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q3	actg	A1st Loan Warrant Condition Proceedsfrom Private Financing A1stLoanWarrantConditionProceedsfromPrivateFinancing	10000000	USD
	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	10131000	USD
CY2015Q4	actg	Accrued Patent Acquisition Related Payments Current AccruedPatentAcquisitionRelatedPaymentsCurrent	1000000	USD
CY2016Q3	actg	Accrued Patent Acquisition Related Payments Current AccruedPatentAcquisitionRelatedPaymentsCurrent	225000	USD
CY2015Q3	actg	Contingent Legal Fees ContingentLegalFees	1972000	USD
	actg	Contingent Legal Fees ContingentLegalFees	12268000	USD
CY2016Q3	actg	Contingent Legal Fees ContingentLegalFees	7709000	USD
	actg	Contingent Legal Fees ContingentLegalFees	22236000	USD
CY2015Q3	actg	Dividendsattributabletocommonstockholdersunderthetwoclassmethod Dividendsattributabletocommonstockholdersunderthetwoclassmethod	-6202000	USD
	actg	Dividendsattributabletocommonstockholdersunderthetwoclassmethod Dividendsattributabletocommonstockholdersunderthetwoclassmethod	-18526000	USD
CY2016Q3	actg	Dividendsattributabletocommonstockholdersunderthetwoclassmethod Dividendsattributabletocommonstockholdersunderthetwoclassmethod	0	USD
	actg	Dividendsattributabletocommonstockholdersunderthetwoclassmethod Dividendsattributabletocommonstockholdersunderthetwoclassmethod	0	USD
CY2016Q3	actg	First Loan Warrant FirstLoanWarrant	700000	USD
	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	-5108000	USD
CY2015Q3	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	10345000	USD
	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	28032000	USD
CY2016Q3	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	7348000	USD
	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	22395000	USD
CY2016Q3	actg	Maximum Investmentin Veritone MaximumInvestmentinVeritone	50000000	USD
CY2015Q4	actg	Patents Accumulated Amortization PatentsAccumulatedAmortization	281495000	USD
CY2016Q3	actg	Patents Accumulated Amortization PatentsAccumulatedAmortization	349646000	USD
CY2015Q4	actg	Patents Net Of Accumulated Amortization PatentsNetOfAccumulatedAmortization	162642000	USD
CY2016Q3	actg	Patents Net Of Accumulated Amortization PatentsNetOfAccumulatedAmortization	94716000	USD
CY2016Q3	actg	Primary Warrant Condition Offering Proceeds PrimaryWarrantConditionOfferingProceeds	15000000	USD
CY2015Q3	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	802000	USD
	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	2531000	USD
CY2016Q3	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	666000	USD
	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	2522000	USD
CY2015Q4	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	14878000	USD
CY2016Q3	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	25009000	USD
CY2016Q3	actg	Second Loan Warrant SecondLoanWarrant	700000	USD
CY2016Q3	actg	Secured Convertible Promissory Note SecuredConvertiblePromissoryNote	20000000	USD
CY2016Q3	actg	Secured Promissory Note Advance SecuredPromissoryNoteAdvance	10000000	USD
CY2016Q3	actg	Secured Promissory Note Advance SecuredPromissoryNoteAdvance	10000000	USD
	actg	Sharebased Compensation Arrangementby Sharebased Payment Award Performancebasedoptionswithmarketconditions Granted SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancebasedoptionswithmarketconditionsGranted	2250000	USD
	actg	Stock Price Vesting Targets Maximum StockPriceVestingTargetsMaximum	10.00
	actg	Stock Price Vesting Targets Minimum StockPriceVestingTargetsMinimum	7.00
	actg	Unrecognizedexpenseforoptionswithmarketconditionsestimatedperiodtoberecognized Unrecognizedexpenseforoptionswithmarketconditionsestimatedperiodtoberecognized	P1Y4M
CY2016Q3	actg	Unrecognizedstockcompensationexpenseforoptionswithmarketconditions Unrecognizedstockcompensationexpenseforoptionswithmarketconditions	4400000	USD
CY2016Q3	actg	Veritone Primary Warrant VeritonePrimaryWarrant	50000000	USD
	actg	Weighted Average Exercise Priceof Performance Based Stock Optionswith Market Based Vesting Conditions WeightedAverageExercisePriceofPerformanceBasedStockOptionswithMarketBasedVestingConditions	5.75
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000934549
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50463380	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	ACACIA RESEARCH CORP
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17347000	USD
CY2016Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	22688000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33500000	USD
CY2016Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	53700000	USD
CY2016Q3	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	194000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-215000	USD
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-59000	USD
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	633146000	USD
CY2016Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	639118000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13688000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39954000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6467000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	27986000	USD
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	71468	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	71468	shares
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3593708	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4410974	shares
CY2015Q4	us-gaap	Assets Assets	347901000	USD
CY2016Q3	us-gaap	Assets Assets	323496000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	183877000	USD
CY2016Q3	us-gaap	Assets Current AssetsCurrent	218066000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	134466000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	157775000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	135223000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116016000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	23309000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-19207000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.125
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.375
CY2016Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.000
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.000
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50651239	shares
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-40008000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	7008000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-43766000	USD
CY2015Q4	us-gaap	Cost Method Investments CostMethodInvestments	0	USD
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50460880	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50651239	shares
CY2016Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50460880	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	51000	USD
CY2016Q3	us-gaap	Common Stock Value CommonStockValue	50000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27130000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-44006000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7194000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43300000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27173000	USD
CY2016Q3	us-gaap	Cost Method Investments CostMethodInvestments	1720000	USD
CY2016Q3	us-gaap	Cost Method Investments CostMethodInvestments	1720000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	210000	USD
CY2016Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	210000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	210000	USD
CY2016Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	210000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	40129000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.87
CY2015Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.01
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.02
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28105000	USD
CY2015Q3	us-gaap	Dividends Dividends	6342000	USD
	us-gaap	Dividends Dividends	19091000	USD
CY2016Q3	us-gaap	Dividends Dividends	0	USD
	us-gaap	Dividends Dividends	0	USD
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.55
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.90
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.14
CY2016Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.58
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.56
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0.00
	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.55
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0092
	us-gaap	Fair Value Inputs Discount For Lack Of Marketability FairValueInputsDiscountForLackOfMarketability	0.07
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	16872000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	6222000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6787000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	19412000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	22111000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	23312000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	94716000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9442000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29604000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8334000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23863000	USD
CY2015Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2016Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	40165000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	40165000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27016000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39502000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16551000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28148000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	337000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	626000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9655000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15774000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2680000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5392000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7411000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20200000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	569000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1191000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	10721000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	3316000	USD
CY2016Q3	us-gaap	Interest Income Other InterestIncomeOther	269000	USD
CY2016Q3	us-gaap	Interest Receivable InterestReceivable	75000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	33746000	USD
CY2016Q3	us-gaap	Liabilities Liabilities	48494000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	347901000	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	323496000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	33225000	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	47922000	USD
CY2015Q3	us-gaap	Licenses Revenue LicensesRevenue	12994000	USD
	us-gaap	Licenses Revenue LicensesRevenue	87540000	USD
CY2016Q3	us-gaap	Licenses Revenue LicensesRevenue	64658000	USD
	us-gaap	Licenses Revenue LicensesRevenue	130730000	USD
CY2015	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0115
CY2015Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	0	USD
CY2016Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	8474000	USD
CY2016Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	8280000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	3944000	USD
CY2016Q3	us-gaap	Minority Interest MinorityInterest	2120000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18153000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1141000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	39307000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41285000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2155000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	23219000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-27310000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-44126000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	7082000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-43456000	USD
CY2015Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-43000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3998000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-186000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-466000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27450000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44691000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7043000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-43456000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-180000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-56000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	261000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	206000	USD
CY2015Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	39830000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	126986000	USD
CY2016Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	48368000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	159084000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-141000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-26836000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-39446000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	16290000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-28354000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1110000	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	365000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	0	USD
CY2016Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	96000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	92000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-274000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-617000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-22000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-94000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-356000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	16000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	42000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2015Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	3465000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	3891000	USD
CY2016Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	0	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	500000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	311000	USD
CY2016Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	362000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-127000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-81000	USD
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	0	USD
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	1720000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	19091000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	23296000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	62633000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	19504000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1000000	USD
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	USD
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	8280000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1358000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2016Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	494455	shares
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4219000	USD
CY2016Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3773000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	82115000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	32352000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	938000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	242000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	-27353000	USD
	us-gaap	Profit Loss ProfitLoss	-40128000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	6896000	USD
	us-gaap	Profit Loss ProfitLoss	-43922000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	272000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	155000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10725000	USD
CY2016Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	14041000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-288131000	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-331587000	USD
CY2015Q3	us-gaap	Royalty Expense RoyaltyExpense	116000	USD
	us-gaap	Royalty Expense RoyaltyExpense	10706000	USD
CY2016Q3	us-gaap	Royalty Expense RoyaltyExpense	17844000	USD
	us-gaap	Royalty Expense RoyaltyExpense	19417000	USD
CY2015Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2164000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8588000	USD
CY2016Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2544000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5754000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	0	USD
CY2016Q3	us-gaap	Short Term Investments ShortTermInvestments	30326000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	310211000	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	272882000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	314155000	USD
CY2016Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	275002000	USD
CY2016Q3	us-gaap	Timesharing Transactions Stated Interest Rate For Notes Receivable TimesharingTransactionsStatedInterestRateForNotesReceivable	0.06
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1729408	shares
CY2016Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	1729408	shares
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	34640000	USD
CY2016Q3	us-gaap	Treasury Stock Value TreasuryStockValue	34640000	USD
CY2015Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2016Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	39000	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2015Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49630369	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49423548	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50618757	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50024047	shares
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	49630369	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49630369	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49423548	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50124302	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50024047	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations. </font><font style="font-family:inherit;font-size:10pt;">Two</font><font style="font-family:inherit;font-size:10pt;"> licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">60%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">27%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">September 30, 2016</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> licensees accounted for </font><font style="font-family:inherit;font-size:10pt;">30%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">27%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">13%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the </font><font style="font-family:inherit;font-size:10pt;">nine months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2016</font><font style="font-family:inherit;font-size:10pt;">. Three licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;">54%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">13%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and two licensees accounted for </font><font style="font-family:inherit;font-size:10pt;">34%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">23%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the </font><font style="font-family:inherit;font-size:10pt;">nine months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">. For the three and </font><font style="font-family:inherit;font-size:10pt;">nine months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">93%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">78%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. For the three and </font><font style="font-family:inherit;font-size:10pt;">nine months</font><font style="font-family:inherit;font-size:10pt;"> ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">5%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">34%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. The Company does not have any material foreign operations.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Two licensees individually represented approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">73%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">22%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">September 30, 2016</font><font style="font-family:inherit;font-size:10pt;">. Two licensees individually represented approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">72%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">21%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at December 31, 2015. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.  </font><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, stock-based compensation expense, impairment of marketable securities and patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, the valuation of the loan and warrants discussed at Note 5 and the application of the acquisition method of accounting for business combinations, require its most difficult, subjective or complex judgments.</font></div></div>

Files In Submission

Name	View Source	Status
0000934549-16-000156-index-headers.html	Edgar Link	pending
0000934549-16-000156-index.html	Edgar Link	pending
0000934549-16-000156.txt	Edgar Link	pending
0000934549-16-000156-xbrl.zip	Edgar Link	pending
actg-20160930.xml	Edgar Link	completed
actg-20160930.xsd	Edgar Link	pending
actg-20160930_cal.xml	Edgar Link	unprocessable
actg-20160930_def.xml	Edgar Link	unprocessable
actg-20160930_lab.xml	Edgar Link	unprocessable
actg-20160930_pre.xml	Edgar Link	unprocessable
actg10q09302016.htm	Edgar Link	pending
ex31109302016.htm	Edgar Link	pending
ex31209302016.htm	Edgar Link	pending
ex32109302016.htm	Edgar Link	pending
ex32209302016.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
graphicactga02a05.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACTG
ACACIA RESEARCH CORP Stock $actg

2016 Q4 Form 10-Q Financial Statement

#000093454916000156 Filed on November 14, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG ACACIA RESEARCH CORP Stock $actg

2016 Q4 Form 10-Q Financial Statement

#000093454916000156 Filed on November 14, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG
ACACIA RESEARCH CORP Stock $actg